Collegium Pharmaceutical authorizes up to $150M share repurchase program through Dec 2026

COLLEGIUM PHARMACEUTICAL, INC

Board authorized $150M share repurchase program, valid through Dec 31, 2026.
Repurchases will be executed on open market based on market conditions and share price.
Program funded by existing cash on hand; timing and amount of purchases discretionary.

item 8.01

COLLEGIUM PHARMACEUTICAL, INC filing history →

Source: SEC EDGAR

accession 0001104659-25-065981

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.